Cupid lifts FY27 revenue guidance to ₹660+ cr after Q1 tops ₹150 cr
First quarter one of strongest in history; management raises full-year target by at least 10% on international demand and new PFSCM supply deal.
What's new
- Q1 FY27 revenue on track to exceed ₹150 cr, one of the strongest quarters ever.
- Full-year FY27 guidance raised by at least 10% to ₹660+ cr from ₹600 cr.
- Long-term supply agreement with PFSCM in Netherlands commenced.
Why this matters
A 10%+ guidance upgrade for a mid-cap signals sustained demand visibility across global markets. The PFSCM deal adds recurring institutional revenue, while favorable USD-INR realization should support margins. This could trigger upward revisions in earnings forecasts and a potential re-rating.
What we're watching
- Q1 FY27 actual revenue and margin print due later.
- Order book conversion and pipeline strength in B2B healthcare.
- Any further guidance updates given current momentum.
The full read
Cupid just told the market that its first quarter of FY27 is shaping up to be one of the strongest in the company's history, with revenue exceeding ₹150 crore. That performance has prompted management to lift its full-year revenue guidance by at least 10% to ₹660+ crore. Hardly surprising given the visibility. The trigger: a string of international B2B healthcare wins, including a new long-term supply agreement with PFSCM in the Netherlands, plus continued momentum in male and female condom segments. For a ₹24,554 crore market cap company with trailing revenue growth of 112%, this guidance upgrade locks in a higher base. The open question is whether margins can hold as scale expands — the company says yes, citing USD-INR realisations and pricing trends. If Q1 delivers on its promise, the next set of analyst models will need a material reset.
Questions answered
- Why did Cupid raise its FY27 revenue guidance?
- Strong Q1 performance (₹150+ cr), expanding international B2B opportunities, a new long-term supply agreement with PFSCM, and robust order visibility across geographies prompted management to lift guidance by at least 10% to ₹660+ cr.
- How significant is the Q1 revenue estimate of ₹150+ cr?
- If achieved, it would be one of Cupid's strongest quarterly performances in history, implying run-rate well above earlier expectations and contributing to the full-year upgrade.
- What is the PFSCM agreement and why does it matter?
- The Partnership for Supply Chain Management (PFSCM) in the Netherlands is a global healthcare procurement body. This long-term supply deal provides recurring institutional demand, adding visibility and diversification to Cupid's revenue.
- What is the margin outlook given the guidance upgrade?
- Management expects healthy margins supported by favorable USD-INR realizations and pricing trends, though specific margin guidance was not provided.